AzTrials
AzTrials

SexualityNCT05770804

Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels

A study testing Face to face education in people with Sexuality and Stigmatization, run by Sakarya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: Failure to exercise reproductive and sexual rights can increase the risk of unwanted pregnancies, HIV and sexually transmitted infections, sexual coercion and violence, especially in young women. Read more about this study

Who is it for?
Ages 18 to 24 years, women onlyHealthy volunteers can take part
Conditions the study is for
Sexuality, Stigmatization, Inflammation
What is being tested?
Face to face education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2022to 25 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

None listed.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sakarya University

    Sakarya, 54000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Education Given to Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels: A Randomized Controlled Study

Aim: Failure to exercise reproductive and sexual rights can increase the risk of unwanted pregnancies, HIV and sexually transmitted infections, sexual coercion and violence, especially in young women. All of these situations affect the physical and mental health of young girls, as well as the health of their families.For this reason, The Effect of Education Given to Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels: A Randomized Controlled Study was planned.

Material and method: The research was conducted as a randomized controlled experimental study. The universe of the research consisted of female students studying at the Faculty of Health Sciences of Ağrı İbrahim Çeçen University between January and June 2022. The sample consisted of individuals who were studying at the Faculty of Health Sciences of Ağrı İbrahim Çeçen University between the same dates and who met the inclusion criteria of the research. "Descriptive Feature Form", "Sexual and Reproductive Health Stigma Scale for Young Women" and sexual health knowledge test were used to collect data. In the analysis of data; percentile distribution, chi-square, Fisher-Freeman- Halton Exact test, paired samples test, t-test in independent groups, Friedman Test, One Way ANOVA test, and post hoc analyzes (Bonferroni, Games Howell, Dunn) were used.

Being tested
Face to face education
Keywords
sexual health, knowledge, Stigma
Medical subject headings
Sexuality, Stereotyping, Inflammation, Social Stigma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Face to face educationBehavioural

    Face-to-face training was provided and supported by booklets.

Study groups in NCT05770804
Study groupRoleWhat they receive
Intervention groupExperimentalFace to face group
Receives: Behavioral: Face to face education
Control GroupNo interventionControl Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Face to face group

    1. The Stigma of Sexual and Reproductive Health in Young Women Scale (SCASS): Hall et al. It was developed by in 2017 to identify the stigma of sexual and reproductive health in women aged 15-24. The original scale consists of 20 items and three sub-dimensions: Accepted stigma, Internalized Stigma, and Attitudes on which Stigma is Based. The accepted stigma sub-dimension consists of a total of 6 items. The lowest score that can be obtained from this dimension is 0, and the highest score is 7. The lowest score that can be obtained from the total of the scale is 0, and the highest score is 20. Each item of the scale is rated as 0=Disagree, 0=Neutral, 1=Agree. The higher the score, the higher the level of stigmatization. An increase in the score obtained from the scale indicates an increase in stigma. The Cronbach alpha value of the scale is 0.74. It is stated that the scale is suitable for all social classes.

    Measured: 6 weeks

  2. Face to face group

    1. Sexual health knowledge test: It was developed by Petili and Gölbaşı in 2017, and its validity-reliability has been made. The test consists of 40 multiple-choice questions and includes 12 sub-dimensions. During the implementation of the CSBT, the participants are asked to carefully read each question and mark the answer they think is correct. Each answer marked correctly by the participant is scored as "1", and each answer marked incorrectly or left blank is scored as "0". The lowest score that can be obtained from CSBT is 0, and the highest score is 40. It is accepted that the higher the score, the higher the level of sexual health knowledge. The Cronbach alpha reliability coefficient of the test was found to be 0.88, and the internal consistency of the test was reported to be high reliability (Evcili \& Gölbaşı, 2017)

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2023
  2. Study start1 Jan 2022
  3. Primary completion1 Dec 2022
  4. Study completion25 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05770804
Sponsor's protocol ID
SakaryaU-metinyildiz-004
Status last verified
Oct 2023
First submitted
2 Feb 2023
Last updated
27 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Face to face education in people with Sexuality and Stigmatization, run by Sakarya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Face to face group (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in